The FDA announced on Oct. 9, 2020, that ANI Pharmaceuticals voluntarily recalled Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules due to an incorrect expiration date on the label. The product was distributed nationwide in the USA.
How to tell if you have it
- Brand: ANI Pharmaceuticals
- Product: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 25 mg, 100-count bottle
- NDC: 43975-281-10
- Lot: 19T16
- Expiration date printed on label: Jan. 2022
- Quantity: 6780 bottles
The hazard
The product was labeled with a 24-month expiration date instead of the required 18 months, according to the FDA recall record.
Context
GovInfoNow's records show ANI Pharmaceuticals has issued three other recalls since Feb. 15, 2022, including a June 2, 2026 recall of hydrOXYzine oral solution for foreign substances and a May 12, 2026 recall of Estradiol Gel due to defective containers. Other recent recalls of similar products include OurPharma's Sept. 3, 2026 Fentanyl Injection Recall regarding IV bag expiry discrepancy and Kirkman's Feb. 18, 2026 Lidocaine Cream Recall concerning stability issues.